Nav: Home

Tax hurts investment in medical device research and development

June 05, 2018

AMES, Iowa - New research shows companies cut funding for research and development in response to a tax imposed on medical devices as part of the Affordable Care Act.

Daeyong Lee, an assistant professor of human development and family studies at Iowa State University, examines how certain provisions of the federal health care reform law have affected families and firms. His latest paper, published in the journal Research Policy, analyzed the 2.3 percent excise tax imposed on medical devices in 2013. The research shows the tax significantly reduced R&D investment, sales revenue, gross margins and earnings by the following amounts:
  • R&D expenditures - $34 million
  • Sales revenue - $188 million
  • Gross margins - $375 million
  • Earnings - $68 million


The study, the first to look at the actual cost for manufacturers, found the tax also affected operating and marketing costs, Lee said.

In the paper, Lee explains that the federal government imposed the tax on the medical device industry because it would benefit from expanded health coverage. The tax applied to everything from needles and syringes to coronary stents, defibrillators and irradiation equipment. Certain items including hearing aids, eyeglasses and contact lenses were exempt. The medical device field is one of the top five R&D intensive industries, and Lee says a decline in investment could have long-term consequences.

"Highly advanced equipment in hospitals is a critical aspect of medical care," Lee said. "Some devices such as coronary stents require high-research investment. If medical device firms stop or reduce that investment, we won't have better equipment and devices for complicated surgeries or procedures."

Passing on the tax burden

Lee looked at different scenarios when calculating the tax effect, controlling for economic factors that might affect investment. To limit the tax impact, firms could have increased prices, passing the burden to consumers. Lee says that did not happen, likely because of the market power of large hospitals and clinics. The data for the study is specific to large customers, not individuals.

In response, medical device firms diversified their customer base and increased global market sales, which were exempt from the tax, Lee said. The findings also suggest firms significantly reduced operating costs for selling, general and administrative expenses, but not advertising and labor expenses.

Raising revenue without harming research

Congress passed an appropriations act in 2015, which included a two-year moratorium on the medical device excise tax. In January, it was extended to 2020, Lee said. Given the study findings, he says the moratorium could provide time to consider other tax options that do not target a single industry. In the paper, Lee suggests policymakers expand the tax base and include other industries, such as health insurance companies, which also have benefited from increased demand as a result of the health care reform act.

"If there is a broader tax base, the negative effects will be reduced," Lee said. "The government needs to raise revenue to cover the costs of the Affordable Care Act, but there are other ways to do it without harming a research and development intensive industry."
-end-


Iowa State University

Related Affordable Care Act Articles:

More breast cancers were diagnosed at early stage after Affordable Care Act took effect
A Loyola University Chicago study published this month has found an increase in the percentage of breast cancer patients who were diagnosed in early Stage 1, after the Affordable Care Act took effect.
ACP expresses 'strongest opposition' to Better Care Reconciliation Act of 2017
The American College of Physicians (ACP) expresses our strongest possible opposition to the Better Care Reconciliation Act (BCRA) of 2017, legislation to repeal and replace the Affordable Care Act (ACA).
Disappointed by House action, AGS urges Senate to reject amended American Health Care Act
The American Geriatrics Society (AGS) remains opposed to the amended American Health Care Act (AHCA) that today passed the US House of Representatives despite serious concerns from geriatrics experts and a host of other stakeholders across health care.
Most new to Medicaid have no other option if Affordable Care Act repealed
Almost everyone covered through Ohio's Medicaid expansion would have no other viable insurance option should the Affordable Care Act be repealed, a new study has found.
American Geriatrics Society addresses American Health Care Act
As an organization dedicated to the health and well-being of us all as we age, the American Geriatrics Society (AGS) today voiced opposition to several components of the newly released American Health Care Act -- legislation to repeal and replace the Affordable Care Act (ACA), and legislation AGS experts believe would harm access to key health services for older adults, caregivers, and healthcare professionals.
Affordable Care Act boosted primary care access for Medicaid patients
Since the introduction of the Affordable Care Act, which provided access to health insurance to millions of previously uninsured adults in the United States, the availability of appointments with primary care physicians has improved for patients with Medicaid and remains unchanged for patients with private coverage, according to new research.
Most primary care doctors 'strongly endorse' key elements of the Affordable Care Act
Proponents of repealing the Affordable Care Act, including President Donald Trump's nominee for Secretary of Health and Human Services, Tom Price, have argued that the law places an undue burden on physicians.
Affordable Care Act helped the chronically ill, but many still can't get care they need
The Affordable Care Act provided insurance coverage and improved access to medical care for Americans with chronic diseases, but a year after the law took full effect, many remained without coverage and faced significant barriers to getting regular medical care.
Affordable Care Act made cancer screening more accessible for millions, study finds
From 2011 to 2013, the ACA resulted in an 8 percent increase in the diagnoses of early-stage colorectal cancer among US seniors aged 65 and older.
Many insured under the Affordable Care Act miss opportunities for financial assistance
A survey by investigators at the Mongan Institute Health Policy Center at Massachusetts General Hospital found that almost one-third of Californians enrolling in individual insurance plans offered under the Affordable Care Act in 2014 potentially missed opportunities to receive financial assistance with either premium payments, out-of-pocket costs or both.

Related Affordable Care Act Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...